DE602005017788D1 - Diagnose- und prognoseverfahren der nichtalkoholischen steatohepatitis (nash) - Google Patents

Diagnose- und prognoseverfahren der nichtalkoholischen steatohepatitis (nash)

Info

Publication number
DE602005017788D1
DE602005017788D1 DE602005017788T DE602005017788T DE602005017788D1 DE 602005017788 D1 DE602005017788 D1 DE 602005017788D1 DE 602005017788 T DE602005017788 T DE 602005017788T DE 602005017788 T DE602005017788 T DE 602005017788T DE 602005017788 D1 DE602005017788 D1 DE 602005017788D1
Authority
DE
Germany
Prior art keywords
nash
alcoholic steatohepatitis
diagnosis
prognosis method
fingerprint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017788T
Other languages
English (en)
Inventor
De La Paz Jose Maria Mato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One Way Liver Genomics SL
Original Assignee
One Way Liver Genomics SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Way Liver Genomics SL filed Critical One Way Liver Genomics SL
Publication of DE602005017788D1 publication Critical patent/DE602005017788D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE602005017788T 2004-07-23 2005-07-08 Diagnose- und prognoseverfahren der nichtalkoholischen steatohepatitis (nash) Active DE602005017788D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103540A EP1619257A1 (de) 2004-07-23 2004-07-23 Methode zur in vitro Diagnose von nichtalkoholischer Steatohepatitis
PCT/EP2005/007535 WO2006008031A1 (en) 2004-07-23 2005-07-08 Diagnostic and prognostic methods of non-alcoholic steatohepatitis (nash)

Publications (1)

Publication Number Publication Date
DE602005017788D1 true DE602005017788D1 (de) 2009-12-31

Family

ID=34929372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017788T Active DE602005017788D1 (de) 2004-07-23 2005-07-08 Diagnose- und prognoseverfahren der nichtalkoholischen steatohepatitis (nash)

Country Status (6)

Country Link
US (1) US20070231811A1 (de)
EP (2) EP1619257A1 (de)
AT (1) ATE449189T1 (de)
DE (1) DE602005017788D1 (de)
ES (1) ES2336928T3 (de)
WO (1) WO2006008031A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007122799A1 (ja) * 2006-03-29 2007-11-01 Yamasa Corporation 肝障害の検出方法、判定方法及び予測方法
CA2669260C (en) 2006-11-09 2019-01-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Differential gene expression in physiological and pathological angiogenesis
US7824871B2 (en) * 2007-06-14 2010-11-02 George Mason Intellectual Properties Methods of diagnosing non-alcoholic steatohepatitis (NASH)
EP2227689B1 (de) 2007-11-02 2012-12-26 Metabolon, Inc. Biomarker für fettleberkrankheit und verfahren zur verwendung davon
EP2157431A1 (de) * 2008-08-11 2010-02-24 One Way Liver Genomics, S.L. Verfahren zur NASH-Diagnose unter Verwendung von Stoffwechselprofilen
EP2309276A1 (de) 2009-09-22 2011-04-13 One Way Liver Genomics, S.L. Verfahren zur Diagnose von nichtalkoholischer Steatohepatitis basierend auf einem metabolomischen Profil
CN111929440A (zh) * 2020-07-29 2020-11-13 西南医科大学附属中医医院 一种基于磁微粒化学发光免疫法检测dnase1l3的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1869463A4 (de) * 2005-04-15 2010-05-05 Becton Dickinson Co Sepsisdiagnose

Also Published As

Publication number Publication date
US20070231811A1 (en) 2007-10-04
ES2336928T3 (es) 2010-04-19
EP1771580A1 (de) 2007-04-11
WO2006008031A1 (en) 2006-01-26
ATE449189T1 (de) 2009-12-15
EP1771580B1 (de) 2009-11-18
EP1619257A1 (de) 2006-01-25

Similar Documents

Publication Publication Date Title
DE602005017788D1 (de) Diagnose- und prognoseverfahren der nichtalkoholischen steatohepatitis (nash)
TW200745556A (en) Biomarkers for liver fibrotic injury
WO2010019550A3 (en) Method of identifying disease risk factors
Tryndyak et al. Interstrain differences in the severity of liver injury induced by a choline-and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism
WO2010056351A3 (en) Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
NO20074762L (no) Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter
NO20064226L (no) mRNA-profering i spytt, biomarkorer og beslektede fremgangsmater og sett av deler
WO2008013910A3 (en) Methods for identifying, diagnosing, and predicting survival of lymphomas
WO2007086980A3 (en) Methods of determining the risk of developing coronary artery disease
WO2004076679A3 (en) Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer
BRPI0612169A2 (pt) métodos prognósticos, métodos de detecção, de distinção, de identificação, de determinação e de monitoramento relacionados com cáncer de pulmão, métodos para amplificação de um ácido nucléico que codifica c-met humano , biomarcadores de cáncer de pulmão, agentes de imagem de cáncer de pulmão, polinucleotìdeos, agente s de ligação de antìgeno, conjuntos, meios legìveis em computador e kits e/ou artigos de fabricação
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2002079411A3 (en) Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
WO2005083115A3 (de) Verfahren zur erkennung von sepsis
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
WO2007030531A3 (en) Reagents for testing and molecular imaging of liver cancer
WO2006015312A3 (en) Prognosis of breast cancer patients
ATE414180T1 (de) Verwendung der gene kir2.3 und drd2 als molekulare marker zur diagnose von schizophrenie
WO2010127417A3 (en) Hepatocellular carcinoma
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2006133923A3 (en) Diagnosis, prognosis and prediction of recurrence of breast cancer
WO2008012362A3 (en) New protein isoforms and uses thereof
WO2005118879A3 (en) Identification of tumors
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition